Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma

Gian Carlo Mattiucci, Rosa Autorino, Giuseppe Roberto D'Agostino, Francesco Deodato, Gabriella Macchia, Vincenzo Perri, Andrea Tringali, Alessio Giuseppe Morganti, Massimiliano Mutignani, Vincenzo Valentini

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. Methods: A systematic review of recently published literature was completed. Recent studies using radiotherapy with survival data, resection rates and quality of life data have been analyzed. Results: There are no randomized trials regarding the treatment of extrahepatic cholangiocarcinoma. The bulk of available studies suggest that in some cases radio-chemotherapy can be used as adjuvant therapy. Radiotherapy could also have a role in unresectable cholangiocarcinoma: external radiotherapy or intraluminal brachytherapy - alone or in combination - could improve the outcome in selected patients.Finally, radiotherapy, and in particular intraluminal brachytherapy, could be used as a palliative treatment to improve the quality of life and in controlling symptoms. Conclusion: The role of radiotherapy in extrahepatic cholangiocarcinoma remains undefined due to the lack of randomized trials or otherwise properly controlled studies.

Original languageEnglish
Pages (from-to)58-67
Number of pages10
JournalCritical Reviews in Oncology/Hematology
Volume90
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Extrahepatic Bile Ducts
Brachytherapy
Radiotherapy
Carcinoma
Cholangiocarcinoma
Quality of Life
Radio
Palliative Care
Drug Therapy
Survival
Therapeutics

Keywords

  • Brachytherapy
  • Intraoperative radiotherapy
  • Palliative therapy
  • Radio-chemotherapy
  • Resectable cholangiocarcinoma
  • Unresectable cholangiocarcinoma

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Cite this

Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma. / Mattiucci, Gian Carlo; Autorino, Rosa; D'Agostino, Giuseppe Roberto; Deodato, Francesco; Macchia, Gabriella; Perri, Vincenzo; Tringali, Andrea; Morganti, Alessio Giuseppe; Mutignani, Massimiliano; Valentini, Vincenzo.

In: Critical Reviews in Oncology/Hematology, Vol. 90, No. 1, 2014, p. 58-67.

Research output: Contribution to journalArticle

Mattiucci, GC, Autorino, R, D'Agostino, GR, Deodato, F, Macchia, G, Perri, V, Tringali, A, Morganti, AG, Mutignani, M & Valentini, V 2014, 'Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma', Critical Reviews in Oncology/Hematology, vol. 90, no. 1, pp. 58-67. https://doi.org/10.1016/j.critrevonc.2013.10.007
Mattiucci, Gian Carlo ; Autorino, Rosa ; D'Agostino, Giuseppe Roberto ; Deodato, Francesco ; Macchia, Gabriella ; Perri, Vincenzo ; Tringali, Andrea ; Morganti, Alessio Giuseppe ; Mutignani, Massimiliano ; Valentini, Vincenzo. / Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma. In: Critical Reviews in Oncology/Hematology. 2014 ; Vol. 90, No. 1. pp. 58-67.
@article{d713ae25ec5a4dbc94c8db8457fcd338,
title = "Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma",
abstract = "Background: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. Methods: A systematic review of recently published literature was completed. Recent studies using radiotherapy with survival data, resection rates and quality of life data have been analyzed. Results: There are no randomized trials regarding the treatment of extrahepatic cholangiocarcinoma. The bulk of available studies suggest that in some cases radio-chemotherapy can be used as adjuvant therapy. Radiotherapy could also have a role in unresectable cholangiocarcinoma: external radiotherapy or intraluminal brachytherapy - alone or in combination - could improve the outcome in selected patients.Finally, radiotherapy, and in particular intraluminal brachytherapy, could be used as a palliative treatment to improve the quality of life and in controlling symptoms. Conclusion: The role of radiotherapy in extrahepatic cholangiocarcinoma remains undefined due to the lack of randomized trials or otherwise properly controlled studies.",
keywords = "Brachytherapy, Intraoperative radiotherapy, Palliative therapy, Radio-chemotherapy, Resectable cholangiocarcinoma, Unresectable cholangiocarcinoma",
author = "Mattiucci, {Gian Carlo} and Rosa Autorino and D'Agostino, {Giuseppe Roberto} and Francesco Deodato and Gabriella Macchia and Vincenzo Perri and Andrea Tringali and Morganti, {Alessio Giuseppe} and Massimiliano Mutignani and Vincenzo Valentini",
year = "2014",
doi = "10.1016/j.critrevonc.2013.10.007",
language = "English",
volume = "90",
pages = "58--67",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma

AU - Mattiucci, Gian Carlo

AU - Autorino, Rosa

AU - D'Agostino, Giuseppe Roberto

AU - Deodato, Francesco

AU - Macchia, Gabriella

AU - Perri, Vincenzo

AU - Tringali, Andrea

AU - Morganti, Alessio Giuseppe

AU - Mutignani, Massimiliano

AU - Valentini, Vincenzo

PY - 2014

Y1 - 2014

N2 - Background: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. Methods: A systematic review of recently published literature was completed. Recent studies using radiotherapy with survival data, resection rates and quality of life data have been analyzed. Results: There are no randomized trials regarding the treatment of extrahepatic cholangiocarcinoma. The bulk of available studies suggest that in some cases radio-chemotherapy can be used as adjuvant therapy. Radiotherapy could also have a role in unresectable cholangiocarcinoma: external radiotherapy or intraluminal brachytherapy - alone or in combination - could improve the outcome in selected patients.Finally, radiotherapy, and in particular intraluminal brachytherapy, could be used as a palliative treatment to improve the quality of life and in controlling symptoms. Conclusion: The role of radiotherapy in extrahepatic cholangiocarcinoma remains undefined due to the lack of randomized trials or otherwise properly controlled studies.

AB - Background: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. Methods: A systematic review of recently published literature was completed. Recent studies using radiotherapy with survival data, resection rates and quality of life data have been analyzed. Results: There are no randomized trials regarding the treatment of extrahepatic cholangiocarcinoma. The bulk of available studies suggest that in some cases radio-chemotherapy can be used as adjuvant therapy. Radiotherapy could also have a role in unresectable cholangiocarcinoma: external radiotherapy or intraluminal brachytherapy - alone or in combination - could improve the outcome in selected patients.Finally, radiotherapy, and in particular intraluminal brachytherapy, could be used as a palliative treatment to improve the quality of life and in controlling symptoms. Conclusion: The role of radiotherapy in extrahepatic cholangiocarcinoma remains undefined due to the lack of randomized trials or otherwise properly controlled studies.

KW - Brachytherapy

KW - Intraoperative radiotherapy

KW - Palliative therapy

KW - Radio-chemotherapy

KW - Resectable cholangiocarcinoma

KW - Unresectable cholangiocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=84895457575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895457575&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2013.10.007

DO - 10.1016/j.critrevonc.2013.10.007

M3 - Article

VL - 90

SP - 58

EP - 67

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1

ER -